ATF3 is a downstream transcription factor of ROS, and increased levels of ATF3 can reduce the transcriptional level of FAK, reducing prostate cancer cells’ invasiveness (Tian et al., 2021). The gene discussed is ATF3; the disease is prostate carcinoma.